Bococizumab is a novel anti-PCSK9 antibody efficiently developed to combat hypercholesterolemia. This therapeutic agent works by the PCSK9 protein, a key regulator of cholesterol concentrations. By neutralizing the https://gerardzlym789874.blog-gold.com/57321796/bococizumab-a-novel-anti-pcsk9-antibody-for-hypercholesterolemia